tiprankstipranks
Conduit Pharmaceuticals (CDT)
NASDAQ:CDT
US Market

Conduit Pharmaceuticals (CDT) Income Statement

Compare
341 Followers

Conduit Pharmaceuticals Income Statement

Last quarter (Q4 2024), Conduit Pharmaceuticals's total revenue was $1.08B, an increase of Infinity% from the same quarter last year. In Q4, Conduit Pharmaceuticals's net income was $58.38M. See Conduit Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 2.46B$ 0.00$ 0.00$ 0.00
Gross Profit
$ 922.22M$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 606.97M$ 5.56M$ 3.16M$ 3.17M
Depreciation and Amortization
$ 0.00$ 167.90K$ 1.73M$ 484.00K
EBITDA
$ 266.46M$ -324.00K$ -1.43M$ -4.38K
Operating Income
$ 266.46M$ -5.56M$ -3.16M$ -3.17M
Other Income/Expenses
$ -38.52M$ 5.03M$ -1.73M$ -484.00K
Pretax Income
$ 227.94M$ -535.00K$ -4.89M$ -3.66M
Net Income
$ 198.43M$ -535.00K$ -4.89M$ -3.66M
Per Share Metrics
$ ―$ ―$ ―$ ―
Basic EPS
$ 4.88$ -0.18$ -0.28$ -0.21
Diluted EPS
$ 4.80$ -0.18$ -0.28$ -0.21
Weighted Average Shares Outstanding
40.69M 33.49M 17.29M 17.29M
Weighted Average Shares Outstanding (Diluted)
41.30M- 17.29M 17.29M
Currency in USD

Conduit Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis